Role of Procalcitonin and Interleukin-6 in Predicting Cancer, and Its Progression Independent of Infection.
Procalcitonin (PCT) and Interleukin-6 (IL-6) have emerged as biomarkers for different inflammatory conditions. The purpose of the study was to evaluate the role of PCT and IL-6 as biomarkers of cancer and its progression in a large cohort of patients. This cross-sectional study included residual pla...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4492776?pdf=render |
id |
doaj-4eb5a3fc61304a3faf510453e4785897 |
---|---|
record_format |
Article |
spelling |
doaj-4eb5a3fc61304a3faf510453e47858972020-11-24T20:50:01ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01107e013099910.1371/journal.pone.0130999Role of Procalcitonin and Interleukin-6 in Predicting Cancer, and Its Progression Independent of Infection.Anne-Marie ChaftariRay HachemRuth ReitzelMary JordanYing JiangAmmar YousifKumait GarogePoonam DeshmukhZanaib Al HamalJoseph JabbourAlexander HananiaSammy RaadMohamed JamalIssam RaadProcalcitonin (PCT) and Interleukin-6 (IL-6) have emerged as biomarkers for different inflammatory conditions. The purpose of the study was to evaluate the role of PCT and IL-6 as biomarkers of cancer and its progression in a large cohort of patients. This cross-sectional study included residual plasma samples collected from cancer patients, and control subjects without cancer. Levels of PCT and IL-6 were determined by Kryptor compact bioanalyzer. We identified 575 febrile cancer patients, 410 non-febrile cancer patients, and 79 non-cancer individuals. The median PCT level was lower in control subjects (0.029 ng/ml) compared to cancer patients with stage I-III disease (0.127 ng/ml) (p<0.0001) and stage IV disease (0.190 ng/ml) (p<0.0001). It was also higher in febrile cancer patients (0.310 ng/ml) compared to non-febrile cancer patients (0.1 ng/ml) (p<0.0001). Median IL-6 level was significantly lower in the control group (0 pg/ml) than in non-febrile cancer patients with stages I-III (7.376 pg/ml) or stage IV (9.635 pg/ml) (p<0.0001). Our results suggest a potential role for PCT and IL-6 in predicting cancer in non-febrile patients. In addition, PCT is useful in detecting progression of cancer and predicting bacteremia or sepsis in febrile cancer patients.http://europepmc.org/articles/PMC4492776?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Anne-Marie Chaftari Ray Hachem Ruth Reitzel Mary Jordan Ying Jiang Ammar Yousif Kumait Garoge Poonam Deshmukh Zanaib Al Hamal Joseph Jabbour Alexander Hanania Sammy Raad Mohamed Jamal Issam Raad |
spellingShingle |
Anne-Marie Chaftari Ray Hachem Ruth Reitzel Mary Jordan Ying Jiang Ammar Yousif Kumait Garoge Poonam Deshmukh Zanaib Al Hamal Joseph Jabbour Alexander Hanania Sammy Raad Mohamed Jamal Issam Raad Role of Procalcitonin and Interleukin-6 in Predicting Cancer, and Its Progression Independent of Infection. PLoS ONE |
author_facet |
Anne-Marie Chaftari Ray Hachem Ruth Reitzel Mary Jordan Ying Jiang Ammar Yousif Kumait Garoge Poonam Deshmukh Zanaib Al Hamal Joseph Jabbour Alexander Hanania Sammy Raad Mohamed Jamal Issam Raad |
author_sort |
Anne-Marie Chaftari |
title |
Role of Procalcitonin and Interleukin-6 in Predicting Cancer, and Its Progression Independent of Infection. |
title_short |
Role of Procalcitonin and Interleukin-6 in Predicting Cancer, and Its Progression Independent of Infection. |
title_full |
Role of Procalcitonin and Interleukin-6 in Predicting Cancer, and Its Progression Independent of Infection. |
title_fullStr |
Role of Procalcitonin and Interleukin-6 in Predicting Cancer, and Its Progression Independent of Infection. |
title_full_unstemmed |
Role of Procalcitonin and Interleukin-6 in Predicting Cancer, and Its Progression Independent of Infection. |
title_sort |
role of procalcitonin and interleukin-6 in predicting cancer, and its progression independent of infection. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2015-01-01 |
description |
Procalcitonin (PCT) and Interleukin-6 (IL-6) have emerged as biomarkers for different inflammatory conditions. The purpose of the study was to evaluate the role of PCT and IL-6 as biomarkers of cancer and its progression in a large cohort of patients. This cross-sectional study included residual plasma samples collected from cancer patients, and control subjects without cancer. Levels of PCT and IL-6 were determined by Kryptor compact bioanalyzer. We identified 575 febrile cancer patients, 410 non-febrile cancer patients, and 79 non-cancer individuals. The median PCT level was lower in control subjects (0.029 ng/ml) compared to cancer patients with stage I-III disease (0.127 ng/ml) (p<0.0001) and stage IV disease (0.190 ng/ml) (p<0.0001). It was also higher in febrile cancer patients (0.310 ng/ml) compared to non-febrile cancer patients (0.1 ng/ml) (p<0.0001). Median IL-6 level was significantly lower in the control group (0 pg/ml) than in non-febrile cancer patients with stages I-III (7.376 pg/ml) or stage IV (9.635 pg/ml) (p<0.0001). Our results suggest a potential role for PCT and IL-6 in predicting cancer in non-febrile patients. In addition, PCT is useful in detecting progression of cancer and predicting bacteremia or sepsis in febrile cancer patients. |
url |
http://europepmc.org/articles/PMC4492776?pdf=render |
work_keys_str_mv |
AT annemariechaftari roleofprocalcitoninandinterleukin6inpredictingcanceranditsprogressionindependentofinfection AT rayhachem roleofprocalcitoninandinterleukin6inpredictingcanceranditsprogressionindependentofinfection AT ruthreitzel roleofprocalcitoninandinterleukin6inpredictingcanceranditsprogressionindependentofinfection AT maryjordan roleofprocalcitoninandinterleukin6inpredictingcanceranditsprogressionindependentofinfection AT yingjiang roleofprocalcitoninandinterleukin6inpredictingcanceranditsprogressionindependentofinfection AT ammaryousif roleofprocalcitoninandinterleukin6inpredictingcanceranditsprogressionindependentofinfection AT kumaitgaroge roleofprocalcitoninandinterleukin6inpredictingcanceranditsprogressionindependentofinfection AT poonamdeshmukh roleofprocalcitoninandinterleukin6inpredictingcanceranditsprogressionindependentofinfection AT zanaibalhamal roleofprocalcitoninandinterleukin6inpredictingcanceranditsprogressionindependentofinfection AT josephjabbour roleofprocalcitoninandinterleukin6inpredictingcanceranditsprogressionindependentofinfection AT alexanderhanania roleofprocalcitoninandinterleukin6inpredictingcanceranditsprogressionindependentofinfection AT sammyraad roleofprocalcitoninandinterleukin6inpredictingcanceranditsprogressionindependentofinfection AT mohamedjamal roleofprocalcitoninandinterleukin6inpredictingcanceranditsprogressionindependentofinfection AT issamraad roleofprocalcitoninandinterleukin6inpredictingcanceranditsprogressionindependentofinfection |
_version_ |
1716804991845400576 |